Patent · US Active

Mycobacterium tuberculosis—thioredoxin reductase inhibitor as an antitubercular agent

US11078185B2 · kind B2 · utility

0Cited by

0References

6Claims

0Family size

Assignee

TECHNISCHE UNIVERSITÄT DORTMUND · DE

Inventors

Oliver Koch · Eppelheim, DE
Luis Bering · Dortmund, DE

Key dates

Filing date	Dec 19, 2019
Grant date	Aug 3, 2021
Priority date	—
Expiry date	Dec 19, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/12
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The invention relates to Mycobacterium tuberculosis-thioredoxin reductase inhibitors, processes for the preparation thereof, drugs containing said compounds, and the use of said compounds for manufacturing drugs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.